Marzena T. Szwed
Position: Postdoc
Phone: +47 22 78 18 33
Email:

 
Publications

2016

Szwed M, Kania KD, Jóźwiak Z. Assessment of pro-apoptotic activity of doxorubicin-transferrin conjugate in cells derived from human solid tumors. International Journal of Biochemistry Cell Biology. 2016, 70: 57-67.

Szwed M, Wrona D, Kania KD, Koceva-Chyla A, Marczak A. Doxorubicin-transferrin conjugate triggers pro-oxidative disorders in solid tumor cells. Toxicology in vitro. 2016, 31: 60-71.

Szwed M, Santos-Oliveira R. Nanoparticles with therapeutic properties generate various response of human peripheral blood mononuclear cells. Journal of Nanoscience and Nanotechnology. 2016, 15: 1-6.

Sarcinelli MA, Albernaz MS, Szwed M, Iscaife A, Leite KR, Junqueira MS, Bernardes ES, da Silva EO, Tavares MI, Santos-Oliveira R. Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals. Journal of OncoTargets and Therap. 2016, 9: 5847-5854.

Braga Ligiero T, Cerqueira-Coutinho C, de Souza Albernaz M, Szwed M, Soares Bernardes E, Vergara Wasserman MA, Santos-Oliveira R. Diagnos in ggastrointestinal stromal tumours by single photon emission computed tomography using nano-radiopharmaceuticals based on bevacizumab monoclonal antibody. Biomedical Physics & Engineering  Express 2 2016, doi: 10.1088/2057-1976/2/4/045017

2015

Szwed M, Laroche-Clary A, Robert J, Jóźwiak Z. Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation. Cellular Oncology. 2015, 9: 107-118.

Szwed M, Kania KD, Jóźwiak Z. Toxicity of doxorubicin-transferrin conjugate is connected to the modulation of Wnt/β-catenin pathway in human leukemia cells. Leukemia Research. 2015, 39: 1096-1102.

do Carmo FS, Rocha Pinto S, Camões Orlando MM, de Souza Albernaz M, de Souza Junqueira M, Bernardes ES, Cerecetto H, Moglioni A, Kozempel J, Szwed M, Missailidis S, Santos-Oliveira S. Nano-Aptamer for Breast Cancer Imaging: Initial Considerations, Journal of Diagnostic Imaging in Therapy. 2015, 2:  41-49.

2014

Szwed M, Matusiak A, Laroche-Clary A, Robert J, Marszalek I, Jóźwiak Z. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells. Toxicololy in vitro. 2014, 28: 187-197.

Rogalska A, Szwed M, Rychlik B The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells. Scientific World Journal. 2014, doi: 10.1155/2014/819548.

Szwed M, Laroche-Clary A, Robert J, Jóźwiak Z. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines. Chemico-Biological Interactions. 2014, 3: 140-148.

Szwed M, Kania KD, Jóźwiak Z. Molecular damage caused by generation of reactive oxygen species in the redox cycle of doxorubicin-transferrin conjugate in human leukemia cell lines. Leukemia & Lymphoma. 2014, 27: 1-9.

Szwed M, Jóźwiak Z. Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells. Mutation Research Res Genet Toxicol Environ Mutagen. 2014, 771: 53-63.

Szwed M, Kania KD, Jóźwiak Z. Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin - transferrin conjugate. Biochimie. 2014, 107: 358–366.

Szwed M, Kania KD, Jóźwiak Z. Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin. Cellular Oncology. 2014, 37: 421-428.

2013

Rogalska A, Marczak A, Gajek A, Szwed M, Śliwińska A, Drzewoski J, Jóźwiak Z. Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B. Toxicology in vitro. 2013, 27: 239-249.

2011

Śliwinska A, Rogalska A, Szwed M, Kasznicki J, Joźwiak Z, Drzewoski J. Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells, Molecular Biology Reports. 2011, 39: 5253-5267.

Kopka A, Janiszewska S, Szwed M, Duda W, Bukowska B The effect of alendronate sodium on human erythrocytes. Environmental Toxicology and Pharmacology. 2011, 32: 306-314.

Rogalska A, Gajek A, Szwed M, Jóźwiak Z, Marczak A. The role of reactive oxygen species in WP 631 - induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin. Toxicology in vitro. 2011, 25: 1712-1720.

2010

Rogalska A, Szwed M, Jóźwiak Z. Aclarubicin-induced apoptosis and necrosis in cells derived from human solid tumours, Mutation Research Genet Toxicol Environ Mutagen. 2010, 700: 1-10.